This study examined the initiation and logistics, funding, perceived barriers and benefits, and disruption of school activities by school-located influenza vaccination (SLIV) programs conducted during the 2008-2009 influenza season. Seventy-two interviews using a structured protocol were conducted with 26 teachers, 16 school administrators, and 30 health care professionals from 34 schools in 8 school districts. SLIV programs used a variety of locations, scheduling and staffing options, and methods for receiving parental consent and screening children. Health care professionals were primarily responsible for implementing SLIV programs, and most administrators and health care professionals considered programs easy to initiate. Health care professionals identified successful programs as requiring adequate planning/coordination, a dedicated program coordinator, and a consistent funding source. Most respondents (96%) reported minimal school-day disruptions. The perception of most stakeholders is that SLIV programs can be relatively easy to initiate, minimally disruptive and can become more efficient with experience, especially with feedback from all stakeholders.
Introduction
Influenza is responsible for approximately 200,000 hospitalizations and 36,000 deaths each year in the United States (Thompson et al., 2003; Thompson et al., 2004) . While the vast majority of hospitalizations and deaths occur in the elderly, children are recognized as a primary vehicle for the transmission of the influenza virus because they have the highest infection rates and shed the virus in larger quantities and for longer periods of time compared with other age groups (Fiore et al., 2010) . It is these qualities, coupled with close interactions with other children, parents, caretakers, and elderly relatives that ideally position children for effectively transmitting influenza virus (Glezen et al., 1978; Weycker et al., 2005) . Among schoolchildren, influenzarelated rates of 28 febrile illnesses, 63 school days missed, and 20 parental workdays missed per 100 children were reported during a single influenza season (Neuzil, Hohlbein, & Zhu, 2002) . Vaccination for influenza has long been established as a first line of defense against seasonal illness, and the Advisory Committee on Immunization Practices now recommends annual universal pediatric influenza (Centers for Disease Control and Prevention, 2011) . Vaccination of school-aged children against influenza is an important component in any strategy for reducing the spread of the disease in households and communities (Basta, Chao, Halloran, Matrajt, & Longini, 2009; King et al., 2006) .
One method used to efficiently vaccinate school-aged children is the school-located influenza vaccination (SLIV) program. Vaccination programs in schools were first widely implemented for polio in 1955 and were followed by catch-up vaccinations conducted in schools for rubella (in 1969) and hepatitis B (in the 1990s; Lindley et al., 2008) . Due to the 2009 H1N1 pandemic, the number of SLIV programs increased and evolved quickly as authorities responded to current immunization needs (Wright, 2010) . Therefore, it has become important to consider the perspectives of key stakeholders, including teachers and school administrators, to fully appreciate these programs. Most published anecdotal reports describe SLIV programs only from the perspectives of school nurses and other health care professionals (HCPs; Borja, Amidon, Spellings, Franzetti, & Nasuta, 2009; Carpenter et al., 2007; Effler et al., 2010; Hull & Ambrose, 2011; Hull, Frauendienst, Gundersen, Monsen, & Fishbein, 2008; King, 2006; King et al., 2005; Li, Freedman, & Boyer-Chu, 2009; Mears, Lawler, Sanders, & Katz, 2009; Ransom, 2009; Wiggs-Stayner et al., 2006) .
Two types of vaccines are available for immunization against influenza, an injectable trivalent inactivated vaccine (TIV) and intranasally administered live attenuated influenza vaccine (LAIV). Both vaccines contain influenza virus antigens equivalent to those recommended each year by public health authorities. Whereas TIV vaccines are administered as intramuscular or intradermal injections, LAIV is a live influenza vaccine that is applied as a mist into nasal passages. Because LAIV is attenuated, it does not produce classic influenza-like illness ([ILI] ''FluMist 1 '', 2010) . In the United States, TIV is licensed for use in individuals aged 6 months (the indicated population varies by TIV product), including those with chronic medical conditions (Fiore et al., 2010) . LAIV is licensed for use in nonpregnant individuals 2-49 years of age; LAIV is not recommended for use in individuals with asthma or children younger than 5 years with recurrent wheezing. LAIV should be used with caution in children with a predisposition to Guillain-Barré syndrome and should not be used in children with gentamicin, gelatine, or arginine sensitivity (''FluMist 1 '', 2010). Because both vaccines are grown in eggs, their use is precluded in children with hypersensitivities to egg or egg proteins (Usonis et al., 2010) .
The present study describes the logistics and outcomes of varied elementary SLIV programs in 8 school districts in the United States from the perspectives of elementary school teachers, administrators, and HCPs. The objective of the study was to elicit information about SLIV program initiation and funding, logistics, perceived barriers and benefits, and disruption of school activities.
Method
This study was conducted in two phases: face-to-face focus groups followed by in-depth telephone interviews. In Phase 1, responses from a small number of SLIV program participants were used to formulate questions for the larger group in Phase 2. Before initiation, study protocols for both phases of the study were reviewed and approved by an institutional review board (IRB) which is certified by the U.S. Department of Health and Human Services Office for Human Research Protections and not affiliated with the study sponsor. All data acquisition occurred during the 2008-2009 influenza season, before declaration of the H1N1 pandemic in June 2009. Interviewers for both phases were employees of RTI Health Solutions. All interviewers had graduate degrees, previous qualitative research experience, and had also completed training with the current study interviewer protocols.
Identification of Schools for Recruitment
Phase 1 and 2 recruitment efforts occurred simultaneously. The goal was to identify two school districts for Phase 1 and six school districts for Phase 2. For Phase 1 of the study, a list of potential school districts that participated in SLIV programs for greater than equal to two previous influenza seasons and information about the influenza vaccine program for each district was provided by the study sponsor and manufacturer of the intranasal influenza vaccine (MedImmune, LLC, Gaithersburg, MD). These data were further supplemented with data gathered from Internet searches, media reports, and state-and district-level organizations. 1 Based on the information provided by this list and information gathered independently from the sponsor, districts were rated as high, medium, and low priority based on their probability of participation. Seven districts were rated as high priority. All of these districts had a high project probability with robust, experienced programs. These also represented a mix of districts that used intranasal vaccine exclusively and districts that used a combination of intranasal/injectable vaccines. Several districts were given a high priority because of their proximity to the researchers. One hundred districts were designated as medium priority. These districts had a high or medium project probability. The remaining districts were ranked as low priority because they required a district research application or they had a low project probability.
Phase 1. One school district in Indiana and one in Texas were selected based on their availability and interest in the study and their geographic, demographic, and program diversity. Brief telephone interviews were conducted with nurse coordinators in both districts to discuss program origins and sources of funding. In February and March 2009, interviews and focus groups with teachers, administrators, and HCPs were conducted to provide a range of perspectives and insights about SLIV programs and to identify relevant topics for questionnaire development in Phase 2.
Two interviews and two focus groups were conducted by two experienced moderators using a semistructured discussion guide. Participants were first asked to describe, in their own words, their experiences and overall impressions of SLIV programs in their school district. Moderators asked about the genesis and continuation of the SLIV programs, vaccine administration, benefits and drawbacks, and response from the community. The discussion guide included probe questions for moderators to use to elicit further details from participants, as needed.
Phase 2. The second phase of the project included indepth telephone interviews with key stakeholders involved in the oversight and administration of elementary SLIV programs during the 2008-2009 influenza season. Based on Phase 1 findings, separate interview protocols were created for teachers, administrators, and HCPs (including school district and health department nurses, as well as nurse's assistants) to focus on topics relevant to each stakeholder group. Because of the similarity of the responses from the various groups in Phase 1, the interview protocols were very similar for each group. General questions addressing communication with parents, program logistics, and impact on school activities were directed to all participants. More specific questions about funding and logistics were asked of the HCPs, and more specific questions about the impact on the school and issues with consent were directed to the administrators and teachers. Interviewers met before and throughout the interview process to ensure that the interview process and recording of responses were standardized as much as possible. (Interview protocols are available upon request from the corresponding author.)
Survey District Recruitment
A total of 107 districts were initially contacted in January 2009 through a letter to the district superintendent, with a follow-up phone call to confirm receipt of the letter and permission to directly contact individual schools. The primary contact in each school district (e.g., superintendent, school district health services staff person) assisted with the recruitment of schools and individual participants who were most knowledgeable about the SLIV program. All participants were given a nominal stipend for their time.
Efforts were made to ensure geographic diversity and a balance between programs offering intranasal influenza vaccine only, injectable influenza vaccine only, and both influenza vaccines. However, only one district could be identified that provided only the injectable vaccine; this site was recruited into the study. Forty-nine school districts did not respond and 17 districts were ineligible for this study because elementary schools were not included in their district's SLIV program. Twenty-five districts required a research application and approval process and were excluded from consideration because of time and resource constraints. Of the remaining 16 school districts, 11 agreed to participate in the telephone interviews, including 8 school districts that offered intranasal vaccine only, 2 districts that offered intranasal and injectable vaccines, and 1 district that offered the injectable vaccine only. The remaining 3 intranasal-only school districts that agreed to participate were excluded from the study because of overrepresentation of this program type. The eight districts that participated encompassed a total of 120 elementary schools, although not all of the schools in each district offered SLIV programs. Two of the eight participating school districts were included in Phase 1 of the study; however, the Phase 2 telephone interviews were conducted with different personnel. All interviews were conducted via telephone by trained interviewers and were completed between March and May 2009.
Analysis
Response frequency distributions by respondent subgroup were used to summarize interview responses. Standard item-level descriptive statistics (e.g., mean, SD, median, frequencies, percentages) were calculated where appropriate. Because missing data were not imputed, some denominators and sample size numbers differ. For the open-ended questions, major themes were identified and reported from the responses provided.
Results

Phase 1, Focus Groups
Both districts in Phase 1 administered the intranasal vaccine, but differed in how they administered the vaccines. The Indiana school district (n ¼ 12 schools) offered the intranasal vaccine during school hours, referring children who were ineligible to clinics or other vaccination programs that offered the injectable vaccine. The Texas school district (n ¼ 9 schools) offered intranasal vaccines to eligible children and provided injectable vaccines to those who were ineligible for the intranasal vaccine; vaccinations were administered during evening clinics, with a parent or guardian present for the vaccinations.
Specific domains were identified in Phase 1 to describe stakeholder experiences with SLIV program development and continuation, including program initiation and funding, program logistics and impact, consent processes and communication with parents, impact on children, lessons learned from previous years and suggested improvements, and plans for program expansion. With few exceptions, responses from stakeholder groups were similar. However, some topics appeared more relevant to certain stakeholder groups; for example, HCPs were more familiar with funding and program initiation and administrators and teachers were more familiar with the consent process and the impact on children.
Phase 2, Survey Results
Seventy-two interviews were conducted, with 5 to 13 participants from each of the eight school districts, including 26 teachers (representing seven districts), 16 school administrators (from eight school districts), and 30 HCPs (from eight school districts; Table 1 ); 34 elementary schools were represented. Overall, 94% of the respondents were female. All teachers were elementary school classroom teachers; 15 administrators were school principals and 1 administrator was an assistant principal. HCPs were school nurses (47%), district nurses (30%), and health department nurses (20%). Overall, the respondents' mean duration in their current occupation was approximately 8 years.
Program Initiation and Funding
School administrators and HCPs reported that a primary motivation for SLIV programs was to have a positive impact on student learning by reducing influenza-related absenteeism and reducing staff exposure to influenza. HCPs also noted the availability of funding as a major driver. A greater percentage of school administrators (n ¼ 10, 63%) reported involvement in the decision to offer the SLIV programs in their own school or district than did HCPs (n ¼ 11, 37%). However, a greater percentage of HCPs reported that they were ''very'' or ''somewhat'' involved in planning and coordinating the influenza vaccination program than administrators (93% vs 75%, respectively). According to HCPs, 23% (n ¼ 7) reported that they had the primary responsibility for planning and initiating the program in their school or district, 17% (n ¼ 5) of HCPs reported that a district administrator or district-level program coordinator (n ¼ 2, 7%) was responsible; 12 (40%) HCPs indicated that the program would continue without any problems if they were to leave their position, suggesting that the programs were well organized and operating efficiently.
The planning and initiation process was rated ''very easy'' or ''easy'' by most administrators and HCPs (81% and 53%, respectively). One HCP noted that her district had a ''great parent response'' and added that the district had ''a lot of help from [the] health department and [the] county nurse.'' HCPs reported that they became more comfortable and efficient with processes and paperwork in subsequent years, and planning and implementing the influenza vaccination program became less difficult.
Respondents employed various resources for initiating and operating SLIV programs (Appendix A). Administrators and teachers sought information from district-level administrative and medical staff and from local or state health authorities with varying success but reported more helpful information from the school nurse and from other resources (school-level administrative staff, letters and newsletters from school district staff, local health departments, and other local health organizations). HCPs found medically related resources, including community physicians, doctors' offices, hospitals, and pharmaceutical company representatives, to be more helpful.
Because the focus groups indicated that HCPs were the most knowledgeable about SLIV funding sources owing to their leadership and familiarity with the coordination of vaccine programs, only HCPs were asked questions regarding funding of vaccines. HCPs from 3 school districts reported that 100% of their vaccines were acquired through the Vaccines for Children (VFC) program, a federally funded program that provides vaccines at no cost to children who would otherwise not be vaccinated because of inability to pay (Birkhead, Orenstein, & Almquist, 2009) . HCPs from two school districts reported that 100% of their vaccine funding came from the local health department, state health authorities, and other state budgets. The remaining respondents reported receiving funding from multiple sources, including those listed above, and from their school systems, national grants, manufacturer's donations, or unknown sources. HCPs reported the most important sources of program success to be adequate planning and coordination, the existence of a dedicated program coordinator, and a reliable funding stream. Other necessary features of a successful program included ''support by the district and in each individual school,'' ''endorsement by high-ranking medical advocate or professional,'' and ''getting the word out that the program is available.'' Six (20%) HCPs stated that the school districts incurred no costs beyond the vaccines. Of those reporting additional expenditures, expenses for supplies, photocopying, food, and travel were identified. These additional costs were covered by a variety of funding sources including state and school district and nurses' annual budgets. Other sources of funding included the local health department, grants, donations, and uncompensated volunteer efforts. One HCP reported that a $10 fee was assessed to parents at the time of vaccination to cover additional costs.
SLIV Program Operations
To gain an understanding of the current scope of the SLIV programs, stakeholder groups were asked to estimate the discussed the parental consent process. Some HCPs (n ¼ 7, 23.3%) also reported that their schools or districts referred to a student medical history form to determine vaccination eligibility.
The most commonly reported approach to receiving parental consent was to send the consent forms home with students (Appendix B). Teachers generally rated the level of difficulty in obtaining completed consent forms from parents as easy; most teachers indicated that the process was simple and successful: ''the consenting process is basic the way it is now, nothing to simplify.'' Other teachers noted possible ways to improve the process by indicating that the district ''might get more participation if [they] talk to parents directly''; another teacher suggested an e-mail notice to parents because ''not all parents may get information sent through the kids.'' While some schools focused on parent communication, one stakeholder noted the importance of student incentives to increase participation: ''Class with highest number of forms returned earned a pizza party. Students rewarded by teachers (e.g., a piece of candy) for returning the forms.''
Respondents reported that parents did not raise many issues related to the influenza vaccinations. Most teachers, administrators, and HCPs spontaneously reported that parents' primary concerns centered on influenza vaccine adverse events and the misconception that influenza vaccinations can cause influenza illness. Parents also asked questions regarding vaccine eligibility, specifically asking about asthma and egg allergies. Participants from several districts expressed that a few parents were vocal about a ''sort of antivaccine'' attitude. One administrator said, ''Some think [the] flu shot or vaccine may cause the flu'' and HCPs noted similar concerns. Stakeholders often noted that the concerns raised by parents regarding influenza vaccinations were because of a lack of education and that more information should be available for parents. Teachers mentioned parental concerns about children with other disorders or conditions: ''Parents were worried about students who had diseases that may cause issues with the flu vaccine, those with autism or asthma.'' One administrator said ''[Being] unaware and uneducated of reasons for vaccination make apprehensive parents.'' Respondents were queried regarding staffing, medical screening of children, and when vaccinations were administered (ie, during or after school; Table 2 ). Some respondents reported that the teacher or HCP would escort the entire classroom to be vaccinated all at once; in other instances, teacher's assistants, guidance counselors, the principal, or parent volunteers would escort children individually or in small groups to their vaccinations. Most respondents indicated that vaccinations were provided in the school nurse's office, the infirmary, or ''somewhere else,'' including vacant classrooms, conference rooms, teachers' workrooms, gyms, libraries, or auditoriums.
For SLIV programs offering intranasal and injectable influenza vaccines, HCPs reported that the screening process for medical eligibility was the most important determinant in deciding which vaccine a child would receive. Of the schools that offered both vaccines, the intranasal vaccine was considered the default vaccine unless the child was ineligible. During the screening process, some discrepancies arose between parental information found on the consent form and the school's medical information; asthma was the principal condition for which conflicting information was obtained, requiring case-by-case resolution.
Disruption of School Activities
Overall, the consensus among respondents was that there was minimal school and classroom disruption during the scheduled vaccination times. Teachers estimated that it took approximately 5-25 min to vaccinate all children who received parental consent in a classroom. HCPs estimated that the total time required to vaccinate one child was, on average, 2.4 min and the total time to vaccinate all eligible children in a single school ranged from <1 hr to a few days. HCPs in schools and districts where both the intranasal and injectable vaccines were available reported that injections took longer to administer than the intranasal influenza vaccine because of vaccine preparation and student cooperation. One HCP explained, ''There is more preparation-psychologically preparing the kids, calming them down''; another HCP added, ''Because [of] the time involved in preparing the shot, comforting, applying a band-aid, etc.'' Stakeholders reported that children seemed more anxious before and more upset after receiving the injectable vaccine compared with the intranasal vaccine (Table 3) .
Program Continuation
Stakeholders were asked to provide suggestions for improving their SLIV programs. Across all respondent groups, there was a preference for offering both an intranasal and injectable vaccine in future years because respondents felt it was best for parents to have a vaccine choice (Figure 1 ). Of the 72 respondents, 15 favored using the intranasal vaccine only and 1 favored using the injectable vaccine only.
In exploring what additional changes the stakeholders wanted to ensure the successful continuation of their SLIV, we examined the additional comments made by the study participants. Teachers conveyed they wanted more publicity for the program: ''advertise more. A lot of people . . . did not know the vaccine was available''; ''let . . . more parents know about program. Use the phone messaging system.'' Teachers also recognized the need for ''sending out information at an earlier date'' and ''simplify[ing] information [regarding the program] for parents who are not very well educated.'' One teacher suggested ''having the nurse come into the classroom to talk to the children before flyers go out to explain the process because anxiety is related to unawareness.'' 2 Administrators provided additional insight. One administrator simply said ''dissemination of information''; another said, ''[We] need to work harder to get the information out there more.'' Administrators also recommended having ''information ready for summer so [we] can begin to talk to parents'' and to ''think of the most commonly asked questions and include those questions and answers to relieve parents' anxiety and decrease parental phone calls.'' HCPs were more concerned with paperwork; one HCP said ''decrease the amount of paperwork'' and another said ''revise and add information to make the consent form more clear [and] clarify medical information.'' A few HCPs also saw the need for better coordination, especially knowing when vaccines would be available.
Discussion
School-located vaccination has the potential to efficiently vaccinate large numbers of children (Schmier, Li, King, Nichol, & Mahadevia, 2008; White, Lavoie, & Nettleman, 1999; Wilson, 2000) and addresses a major barrier of vaccination by ''bringing the vaccines to where the kids are'' (McCauley, Fishbein, & Santoli, 2008) . School-located vaccination programs aimed at influenza have been reported in the literature since the late 1960s (Monto, Davenport, Napier, & Francis, 1970) . More recently, SLIV programs have been shown to reduce ILI, health care use due to ILI, child school absenteeism, and parental missed work (King et al., 2005; King et al., 2006 ). An additional benefit of Overall, how anxious are children before receiving the intranasal vaccine? Teachers 1 (5) 8 (36) 9 (41) 4 (18) 2.7 (0.8) Administrators 0 (0) 8 (57) 6 (43) 0 (0) 2.4 (0.5) HCPs 2 (7) 13 (46) 11 (39) 2 (7) 2.5 (0.7) Overall, how anxious are children before receiving the injectable vaccine? Teachers 3 (50) 3 (50) 0 (0) 0 (0) 1.5 (0.6) Administrators 1 (25) 3 (75) 0 (0) 0 (0) 1.8 (0.5) HCPs 5 (42) 7 (58) 0 (0) 0 (0) 1.6 (0.5) Overall, how upset are children after receiving the intranasal vaccine? Teachers 0 (0) 1 (5) 9 (41) 12 (55) 3.5 (0.6) Administrators 0 (0) 0 (0) 7 (50) 7 (50) 3.5 (0.5) HCPs 0 (0) 0 (0) 13 (46) 15 (54) 3.5 (0.5) Overall, how upset are children after receiving the injectable vaccine? Teachers 2 (33) 1 (17) 2 (33) 1 (17) 2.3 (1.2) Administrators 0 (0) 1 (33) 2 (67) 0 (0) 2.7 (0.6) HCPs 0 (0) 7 (58) 5 (42) 0 (0) 2.4 (0.5)
Note. HCP ¼ health care professional; SD, standard deviation. a The denominator for the percentages is based on the number of those who provided a valid response; modal responses are in boldface. b Responses were graded on a scale of 1 ¼ ''very anxious/upset'' to 4 ¼ ''not at all anxious/upset''.
providing influenza vaccines in a school setting is that an established SLIV program infrastructure could be an important preparation for future influenza pandemics (Glezen, 2006) . The H1N1 pandemic during the 2009-2010 influenza season prompted approximately two thirds of U.S. states to enact pandemic influenza vaccination campaigns in school settings (Centers for Disease Control and Prevention, 2009). Despite the documented benefits of SLIV programs, widespread adoption of these programs has been slow because of real and perceived obstacles. Funding remains a major barrier and challenge to sustainability (Borja et al., 2009; Carpenter et al., 2007; Cawley, Hull, & Rousculp, 2010; Schmier et al., 2008) , although studies have found the costs of the program to be acceptable (Effler et al., 2010; Hull et al., 2008) . Our study found that vaccines were primarily covered through the VFC program, local health departments, state health authorities, and other state funds. Despite the funding and administrative efforts involved in starting a school-located vaccination program, the interview consensus was that planning and implementing an influenza vaccination program was not as difficult in subsequent years compared with the program's first year. This trend is not surprising, given the inherent process improvements and learning that can evolve during multiyear efforts.
The logistics of administering successful SLIV programs have been described by school nurses (Borja et al., 2009; Li et al., 2009; Wiggs-Stayner et al., 2006) , state health departments (Carpenter et al., 2007; Effler et al., 2010; Ransom, 2009) , and others (Hull et al., 2008; Mears et al., 2009 ; National Association of County & City Health Officials, 2009), without directly exploring the level of disruption caused within the school and classroom. In our interviews, the majority of respondents reported minimal school-day disruption, which may be related to the speed of vaccine administration in the mass clinics. In terms of classroom disruption, teachers estimated that it took an average of 13 min to vaccinate all participating students in one classroom, consistent with the 15 and 18 min per classroom cited in other reports (Borja et al., 2009; Schieber & Kennedy, 2008) . HCPs estimated that the total time required to vaccinate one child was slightly more than 2 min, with a range of 1 to 10 min, 3 consistent with reported vaccination times of 1.2 to 2 min per child per nurse with the intranasal vaccine in other school programs (Borja et al., 2009; Hull et al., 2008) . A statewide program in Hawaii found that the median time for a child to undergo registration and vaccination was 4 min and that 90% of children could pass through the clinic in less than 10 min (Effler et al., 2010) . Some interviewees observed that injectable vaccines were more disruptive to clinic flow and took longer to administer than the intranasal vaccine, a position supported in other programs (Mears et al., 2009) . In our study, the majority of teachers noted that children appeared less anxious or upset before and after receiving the intranasal vaccine compared with the injectable vaccine. The link between anticipatory anxiety and the degree of distress experienced during vaccination has been noted previously (Taddio et al., 2009) and should be explored further in future studies. There was a definite preference across all three groups for offering both the intranasal and injectable vaccines so that the needs of the largest number of children could be met. HCPs showed a trend toward supporting the use of the intranasal vaccine for all eligible students and the injectable vaccine for those students ineligible to receive LAIV, reflecting the desire to minimize the use of needles in the school setting. Previous school vaccination programs have shown that 68% to 85% of children are medically eligible for the intranasal vaccine (Hull & Ambrose, 2011) ; a program offering both vaccines could meet the needs of all students and address HCP concerns by reducing exposure to needles (Carpenter et al., 2007; King et al., 2005; Wiggs-Stayner et al., 2006) .
In a systematic literature review on SLIV, Cawley et al. reported that the most significant obstacle to vaccinating children in school was obtaining parental consent (2010) . Other factors associated with lower rates of returned consent forms included lower socioeconomic status (Goldstein, Cassidy, Hodgson, & Mahoney, 2001) , uninsured children (compared with commercial or Medicaid insurance; Middleman, 2004) , male students (Middleman, 2004) , and students in middle or high school (Wilson & Harman, 2000) . The reasons identified for lack of returned consent forms are that parents/guardians either never receive the forms or children fail to return signed forms (Woodruff, Unti, Coyle, & Boyer-Chuanroong, 1996) . Parental education on SLIVs has been shown to increase returned consent forms (Middleman, 2004; Tung & Middleman, 2005; Wilson, 2001; Wilson & Harman, 2000) . Since public meetings held by schools are poorly attended, educating parents through information packets or informing local pediatricians as they are commonly consulted by parents are found to be successful options (Boyer-Chuanroong, Woodruff, Unti, & Sumida, 1997; Woodruff et al., 1996) . Specific changes, including using colored paper, placing a large dot at the signature space, and sending materials in brightly colored envelopes may reduce the number of lost materials and increase the likelihood that parents will receive and review the consent forms . It is also important to print consent forms in all relevant languages for the parents (Harris, Kerr, & Steffen, 1997) .
Increasing student interest can help drive the completion and return of consent forms, and peer incentives, including, for example, a classroom pizza party, were found to be more effective than individual incentives (Unti, Coyle, Woodruff, & Boyer-Chuanroong, 1997) . Peer incentives for classrooms may include postings of returned consent forms (either accepting or declining vaccination), and contests between classrooms or grades for completed forms. Nearly half of the students who were in classes with peer incentives stated (with teacher confirmation) that the incentives were the primary reason for returning the consent forms.
Limitations
The 72 stakeholders that were part of the study were from only eight U.S. school districts. These school districts were part of a convenience sample (107 districts) that was partially identified by the manufacturer of the intranasal vaccine. Therefore, the generalizability of the study results may be limited. Additional bias may have been introduced because most districts enrolled in the study offered the intranasal vaccine and only one injection-only district could be identified. In schools that offered both types of influenza vaccine, this study did not address whether or in what ways children given the injectable vaccine differed from those given the intranasal vaccine (e.g., contraindications, anxieties).
Because of the small sample size and lack of random selection, formal hypothesis tests were not conducted and quantitative comparisons across respondent groups were limited, as were inferences about the importance of different response options. Additionally, because of time constraints and the informal and conversational nature of the interviews, there were departures from the survey protocol question sequence and interview completion, at times resulting in missing data. Special effort to recruit schools with multilevel (including school-based) IRB processes would ensure a broader sample of school districts.
Another limitation is the retrospective nature of the interviews, with a recall period that often involved several months for some questions. In addition, the initial outbreak of the 2009-2010 H1N1 pandemic coincided with our data collection and response results may have been influenced by the emergence of an influenza pandemic. Finally, all interview respondents were from schools that had conducted more than 1 SLIV program in the past. Because we did not capture data from elementary schools that held a single vaccination program and subsequently discontinued the program, our results reflect the characteristics of successful programs and may underestimate the barriers for initiating or continuing vaccination programs.
Conclusions
While clinicians, specifically nurses, are the primary drivers toward successful SLIVs, there are other important partners within the schools to assure that adequate vaccination rates are achievable. Teachers and school administrators are vital members of successful SLIV programs and should be involved in all aspects of the vaccination process including organization, education, and implementation.
Successful implementation of an SLIV program requires advance planning and preparation in terms of financing, completing paperwork, coordinating participants, managing logistics, and appropriating space and staff. Although these requirements are not necessarily perceived as barriers by SLIV coordinators, they reflect the expected complexities of initiating any new health program. Interviewed stakeholders perceived the most important sources of program success to be adequate planning and coordination, the existence of a dedicated program coordinator, and a reliable source of funding. Other studies have shown that adequate planning, including specific steps toward simplifying consent forms, can maximize parental approval.
Future studies on SLIV programs should collect quantitative data from all stakeholders across multiple programs, including schools that had SLIV programs which were subsequently discontinued, to identify best practices. Additionally, more precise estimates of the time required to administer vaccinations at the individual child level, the classroom level, and the school and school district level would assist in planning and resource allocation.
School-based vaccination programs can be relatively easy to initiate and minimally disruptive. Implementation of SLIVs can become more efficient with experience. Lessons learned from teachers, school administrators, and HCPs can help improve future programs and should be able to increase the likelihood of successful SLIV programs.
Appendix A Appendix B Internet/websites HCPs 5 (17) 5 (17) 0 (0) 2 (7) 1.9 (1.1) Superintendent or district-level administrative staff Teachers 3 (12) 3 (12) 0 (0) 1 (4) 1.9 (1.1) Administrators 6 (38) 2 (13) 0 (0) 1 (6) 1.6 (1.0) HCPs 7 (23) 7 (23) 0 (0) 0 (0) 1.5 (0.5) District-level medical staff (e.g., district nurse) Teachers 14 ( 
